TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer

NCT03287674 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Ovarian Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: TIL infusion
DRUG: Interleukin-2
DRUG: Ipilimumab
DRUG: Nivolumab

Sponsor

Inge Marie Svane